Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Oct 14.

Published in final edited form as: Vasc Med. 2019 Jul 5;24(5):414–421. doi: 10.1177/1358863X19859072

Table 2.

Absolute values and changes in mean vessel wall area in the SFA.

	Canakinumab (mm²) Mean ± SD	Placebo (mm²) Mean ± SD	Canakinumab-adjusted ratio to baseline, mean ± SD	Placebo-adjusted ratio to baseline, mean ± SD
Baseline	115.2 ± 31.9 n = 17	116.1 ± 43.9 n = 19
3 Months	117.3 ± 26.7 n = 17	117.8 ± 44.5 n = 15	1.04 ± 0.13	0.99 ± 0.09
12 Months	119.5 ± 40.9 n = 12	98.9 ± 28.3 n = 9	1.05 ± 0.08	1.00 ± 0.16

Geo, geometric; SFA, superficial femoral artery.